{"id":"W4410795567","doi":"10.1200/jco.2025.43.16_suppl.7516","title":"Daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) in patients with newly diagnosed multiple myeloma (NDMM): Subgroup analysis of transplant-ineligible (TIE) patients in the phase 3 CEPHEUS study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Johnson and Johnson","keywords":"Lenalidomide; Medicine; Daratumumab; Bortezomib; Multiple myeloma; Dexamethasone; Subgroup analysis; Oncology; Internal medicine; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001632864,0.0005984118,0.001554555,0.0004027568,0.0002828578,0.000765184,0.000431009,0.0006078804,0.001409824],"category_scores_gemma":[0.001337193,0.0003002228,0.002603422,0.0004963625,0.0002959687,0.0004732422,0.000561801,0.0008617382,0.0001735994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000602283,"about_ca_system_score_gemma":0.0007116944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008443648,"about_ca_topic_score_gemma":0.003064091,"domain_scores_codex":[0.9994343,0.0002364254,0.00005955129,0.0001242621,0.00005636887,0.00008909316],"domain_scores_gemma":[0.999328,0.0001785124,0.0002116897,0.00007806813,0.00002795881,0.0001757178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6694798,0.003640789,0.2643021,0.0007126686,0.01454171,0.0004590115,0.0002947557,0.001589179,0.006730265,0.0001694232,0.001672466,0.03640781],"study_design_scores_gemma":[0.1410081,0.1449705,0.6780757,0.0001882239,0.02067865,0.001439219,0.0005383255,0.004752833,0.002284727,0.0006969327,0.005255336,0.0001113599],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980268,0.001137629,0.00008303163,0.00006021462,0.0000233364,0.0001308944,0.0003347802,0.000003691285,0.0001995932],"genre_scores_gemma":[0.9984537,0.0003237329,0.0001384103,0.000123687,0.00004575139,0.0001037879,0.0005966937,0.00000274489,0.00021147],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001632864,"threshold_uncertainty_score":0.008635521,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05493743037109683,"score_gpt":0.432347701128864,"score_spread":0.3774102707577672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}